UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Successful Salvage Brachytherapy after Infusion of Gold AuroShell Nanoshells for Localized Prostate Cancer in a Human Patient

Advances in radiation oncology, 2023-07, Vol.8 (4), p.101202, Article 101202

2023

Volltextzugriff (PDF)

Stage at presentation and oncologic outcomes for agent orange exposed and non-exposed United States veterans diagnosed with prostate cancer

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.259-259

2021

Volltextzugriff (PDF)

Ability of STAR-CAP staging system to prognosticate risk of subsequent therapies after initial treatment of M0 prostate cancer

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.310-310

2023

Volltextzugriff (PDF)

The lexicon of PET/CT reports in prostate patients: Evaluating confidence

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.232-232

2022

Volltextzugriff (PDF)

Geographical impact on prostate cancer genetic testing eligibility: A preliminary study from an academic cancer center

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10618-10618

2023

Volltextzugriff (PDF)

The Ability of the STAR-CAP Staging System to Prognosticate the Risk of Subsequent Therapies and Metastases After Initial Treatment of M0 Prostate Cancer

Clinical genitourinary cancer, 2024-04, Vol.22 (2), p.426-433.e5

2024

Volltextzugriff (PDF)

Predicting absolute benefit in risk of metastasis of androgen deprivation therapy added to radiation therapy in patients with newly diagnosed prostate cancer using Prolaris

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5030-5030

2023

Volltextzugriff (PDF)

Phase II study of pembrolizumab in combination with radiation with or without olaparib in localized high-risk prostate cancer

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.TPS351-TPS351

2024

Volltextzugriff (PDF)

Temporal trends and predictors in diagnosing pathologic node-positive prostate cancer in clinically node-negative patients

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.128-128

2021

Volltextzugriff (PDF)

Patterns of care and treatment outcomes in locoregional squamous cell carcinoma of the prostate

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.260-260

2021

Volltextzugriff (PDF)

Factors associated with positive germline testing results in men with prostate cancer following NCCN guideline expansion

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.230-230

2020

Volltextzugriff (PDF)

The effect of neoadjuvant chemotherapy on quality of life for patients with muscle invasive bladder cancer (MIBC) undergoing cystectomy

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18614-e18614

2021

Volltextzugriff (PDF)

Mature results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic prostate cancer to bone

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.160-160

2024

Volltextzugriff (PDF)

Risk of secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e19525-e19525

2021

Volltextzugriff (PDF)

Clinical characteristics of men with prostate cancer and evaluation of NCCN prostate cancer guidelines on germline genetic testing outcomes

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.252-252

2019

Volltextzugriff (PDF)

Initial results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic prostate cancer to bone

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.156-156

2023

Volltextzugriff (PDF)

Plasma proteome landscape and impact of the circulatory proteome on clinical outcomes in metastatic prostate cancer

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.237-237

2023

Volltextzugriff (PDF)

Ability of the combined clinical cell-cycle risk score to identify patients that benefit from multi versus single modality therapy in NCCN intermediate and high-risk prostate cancer

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.346-346

2020

Volltextzugriff (PDF)

Incidence and cost of radical prostatectomy for NCCN low-risk prostate cancer in Utah

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.232-232

2021

Volltextzugriff (PDF)

Shifting perceptions of alternative therapies in cancer patients during the COVID-19 pandemic: Results from the Complementary and Alternative Medicine Exposure in Oncology (CAMEO) Study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e24130-e24130

2022

Volltextzugriff (PDF)

Complementary and alternative medicine exposure in oncology (CAMEO) study: A multi-institutional cross-sectional analysis of patients receiving cancer treatment

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18739-e18739

2022

Volltextzugriff (PDF)

NEXT: A phase 2 study of nivolumab adjuvant to chemoradiation in patients (pts) with localized urothelial carcinoma

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.612-612

2024

Volltextzugriff (PDF)

Comparing pretest video genetic education for prostate cancer patients: Do patients need assistance?

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5061-5061

2022

Volltextzugriff (PDF)

NEXT: A single-arm, phase 2, open-label study of adjuvant nivolumab after completion of chemo-radiation therapy in patients with localized muscle-invasive bladder cancer

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.506-506

2022

Volltextzugriff (PDF)

Impact of pretest video genetic education in prostate cancer patients: Do patients need us?

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.68-68

2022

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Englisch
(92)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Successful Salvage Brachytherapy after Infusion of Gold AuroShell Nanoshells for Localized Prostate Cancer in a Human Patient

Stage at presentation and oncologic outcomes for agent orange exposed and non-exposed United States veterans diagnosed with prostate cancer

Ability of STAR-CAP staging system to prognosticate risk of subsequent therapies after initial treatment of M0 prostate cancer

The lexicon of PET/CT reports in prostate patients: Evaluating confidence

Geographical impact on prostate cancer genetic testing eligibility: A preliminary study from an academic cancer center

The Ability of the STAR-CAP Staging System to Prognosticate the Risk of Subsequent Therapies and Metastases After Initial Treatment of M0 Prostate Cancer

Predicting absolute benefit in risk of metastasis of androgen deprivation therapy added to radiation therapy in patients with newly diagnosed prostate cancer using Prolaris

Phase II study of pembrolizumab in combination with radiation with or without olaparib in localized high-risk prostate cancer

Temporal trends and predictors in diagnosing pathologic node-positive prostate cancer in clinically node-negative patients

Patterns of care and treatment outcomes in locoregional squamous cell carcinoma of the prostate

Factors associated with positive germline testing results in men with prostate cancer following NCCN guideline expansion

The effect of neoadjuvant chemotherapy on quality of life for patients with muscle invasive bladder cancer (MIBC) undergoing cystectomy

Mature results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic prostate cancer to bone

Risk of secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality

Clinical characteristics of men with prostate cancer and evaluation of NCCN prostate cancer guidelines on germline genetic testing outcomes

Initial results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic prostate cancer to bone

Plasma proteome landscape and impact of the circulatory proteome on clinical outcomes in metastatic prostate cancer

Ability of the combined clinical cell-cycle risk score to identify patients that benefit from multi versus single modality therapy in NCCN intermediate and high-risk prostate cancer

Incidence and cost of radical prostatectomy for NCCN low-risk prostate cancer in Utah

Shifting perceptions of alternative therapies in cancer patients during the COVID-19 pandemic: Results from the Complementary and Alternative Medicine Exposure in Oncology (CAMEO) Study

Complementary and alternative medicine exposure in oncology (CAMEO) study: A multi-institutional cross-sectional analysis of patients receiving cancer treatment

NEXT: A phase 2 study of nivolumab adjuvant to chemoradiation in patients (pts) with localized urothelial carcinoma

Comparing pretest video genetic education for prostate cancer patients: Do patients need assistance?

NEXT: A single-arm, phase 2, open-label study of adjuvant nivolumab after completion of chemo-radiation therapy in patients with localized muscle-invasive bladder cancer

Impact of pretest video genetic education in prostate cancer patients: Do patients need us?

Suchergebnisse filtern